Introduction {#sec1-1}
============

Vitiated *Dosha* is the basic factor in the manifestation and progress of any disease. *Panchakarma* therapy, specifically the *Samshodhana* like Vamana and *Virechana*, is one of its kinds which aims at the elimination of vitiated *Doshas* from the body so that the disease could be prevented or if the pathology has already established, treated in the most effective manner.

*Virechanakarma* (Therapeutic purgation) is one among the *Panchakarma* therapies, which eliminates excessive vitiated *Dosha* in general and *Pitta Dosha* in particular from the body through the anal route.

Under normal circumstances, if a patient suffers from diarrhea, then certainly there is loss of electrolytes from the body resulting in weakness; development of cramps due to dehydration, and sometimes low blood pressure and renal failure.

However, if purgation is induced through *Virechana* therapy and if *Samyakshuddhi* (features of proper *Virechana*) occurs, no such symptoms occur. The assessment of *Virechana* is based on various parameters termed as *Shuddhi* (cleansing) criteria like *Vaigiki* (number of bouts of stool passed), *Manaki* (quantitative measurement of stools), *Laingiki* (symptoms based assessment), and *Antyaki* (assessment based on end point of purgation) *Shuddhi*.

The *Doshas* eliminated are classified on the basis of number of bouts of evacuation as low, medium, and high quantities (i.e., *Hina, Madhyama*, and *Uttamshuddhi*). These are 10, 20, and 30 times respectively.

After purgation in such high numbers, if there is an electrolyte imbalance, it needs to be evaluated and the levels are to be compared before and after *Virechana* therapy.

The present study was aimed at ascertain the safety of *Virechanakarma* on certain subjective and objective parameters and to evaluate the serum electrolyte levels before and after *Virechanakarma*.

Materials and Methods {#sec1-2}
=====================

The study was conducted as follows:

15 cases were enrolled for *Virechanakarma* at the P.G. Department of Panchakarma. All the registered cases were evaluated for:

Serum sodium levels,Serum potassium levels,Serum chloride levels,Serum calcium levels, before and after *Virechanakarma*.

The results were analyzed statistically using paired *t* test. *P* \> 0.1 were considered insignificant, *P* values in between 0.05 and 0.001 were considered significant while *P* \< 0.001 were taken as highly significant.

Treatment plan (*Virechanakarma*) {#sec2-1}
---------------------------------

The procedure of *Virechanakarma* was performed in three steps.

(1)*Poorvakarma*, i.e., the preparatory procedures; is to be performed before the main therapy, which includes *Deepana* and *Pachana* (use of appetizers and digestives drugs) followed by *Snehapana* (oral administration of medicated ghee) for 3-7 days as per the *Koshtha* (nature of bowel) of the patient until achieving features of adequate oleation. This is followed by *Abhyanga* (external application of oil) and *Swedana* (sudation) for next 3 days(2)*Pradhanakarma* (main procedure), which means administration of *Virechana* drug as per the disease, *Bala* (strength), and *Koshtha* of the patient. The drugs commonly used for inducing *Virechana* in the patients are:*Triphala* decoction prepared from *Haritaki* (*Terminalia chebula*), *Vibhitaki* (*Terminalia bellirica*), and *Amalaki* (*Emblica officinalis*)\[[@ref1]\] between 80 and 160 ml*Katuki* (*Picrorhiza kurroa*)\[[@ref1]\] 15-25 g*Trivrit* (*Operculina turpethum*)\[[@ref1]\] 15-30 gCastor oil 30-50 ml and*Ichchabhedirasa*\[[@ref2]\] 125-250 mg (1-2 tablets) as per the requirement after assessing the *Koshta* and *Vegas*.

The patients are observed for *Samyakshuddhi Lakshana* (symptoms of appropriate *Virechanakarma*).\[[@ref3][@ref4]\]

The classical features observed after *Virechana* are:

*Daurbalyam* (weakness)*Laghavam* (feeling of lightness)*Glani* (fatigue)*Vyadhi nam anuta* or *Anaamayatvam* (subsidence of disease)*Hrid Shuddhi* (clarity in thoracic region)*Varna Shuddhi* (improved complexion)*Buddhi indriya manah Shuddhi* (clarity of thoughts, sensoria, and intellect with a feeling of wellbeing)*Marutasya anulomata* (downward movement of vata)*Kayagneshcha anuvartanam* (improved digestive capacity)*Srotovishuddhi* (clarity of channels)*Indriya samprasado* (improved sensory and motor functions).

(3)*Pashchatakarma* (postoperative procedures) also known as *Samsarjanakrama*, in which the patient is advised for specific code of conduct and dietary regimens for 3-7 days depending upon the number of bouts of bowel evacuated after administering *Virechana* drug.

Inclusion criteria {#sec2-2}
------------------

Patients fit for *Virechanakarma* and presenting with *Samyakshuddhi lakshana*.Patients within the age group of 20-60 years, irrespective of gender and religion.Patients not suffering from any serious disease.The patients in this study were selected irrespective of the disease for which they were advised *Virechanakarma*.

Exclusion criteria {#sec2-3}
------------------

Patients presenting with any serious disease having gross electrolyte imbalance.

Observations and Results {#sec1-3}
========================

Following the classical guidelines for *Virechana*, starting from *Purvakarma*, patients were administered *Snehapana* for an average of 5.13 days in 15 patients. *Snehapana* was stopped when *Samyakashuddhi* features were present in the patients.

Out of 15 patients, two had *Krurakoshtha*, four patients had *Mridukoshtha*, and the remaining nine had *Madhyamakoshtha*.

After a period of 3 days, wherein patients were advised external oleation (*Abhyanga*) and sudation (*Swedana*), *Virechana* drug was administered as per the need of the patient.

The average number of bouts of bowel evacuation (*Vegas*) in the 15 patients was 17.

Analysis of serum electrolyte levels {#sec2-4}
------------------------------------

The assessment of serum sodium level before and after the *Virechana* was within the normal range with an average reduction of 1.80 mmol/L, which was statistically highly significant \[[Table 1](#T1){ref-type="table"}\].

###### 

Statistical analysis of serum electrolyte levels before and after therapy
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Serum chloride level was within the normal range before and after *Virechana karma* with an average reduction of 0.60 mmol/L and this result was statistically significant \[[Table 1](#T1){ref-type="table"}\].

The results obtained for serum potassium levels were well within the normal range before and after *Virechana*. The average reduction after *Virechana* in serum potassium value was 0.043 mmol/L, which was significant statistically \[[Table 1](#T1){ref-type="table"}\].

The data obtained for serum calcium levels reveal that the average before and after values lie in normal range. However, there is an average increase of 0.0934 mmol/L after *Virechana* \[[Table 1](#T1){ref-type="table"}\].

The average systolic pressure before *Virechana* was 123.32 mm of Hg while it was 114.93 mm of Hg after *Virechana* \[[Table 2](#T2){ref-type="table"}\].

###### 

Analysis of vital parameters of the patients
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The average diastolic pressure before *Virechana* was 78.266 mm of Hg while it was 74.66 mm of Hg after *Virechana* \[[Table 2](#T2){ref-type="table"}\].

The average pulse before *Virechana* was 76.8 per minute while that afterwards was 74 per minute \[[Table 2](#T2){ref-type="table"}\].

There has been a transient fall in vital parameters like blood pressure and pulse immediately after *Virechana*. However, these values returned to the normal limits on the next day of *Virechana*.

Discussion {#sec1-4}
==========

The modern day literature suggests that purgation leads to dehydration, electrolyte imbalance and loss of electrolytes, hypotension, and shock.\[[@ref5][@ref6]\] Certain *Vyapada*\'s (complications) of *Virechana karma* and signs and symptoms of excessive *Virechana* are described in Ayurveda which are similar to the features of dehydration and associated complications. Hence *Virechana* being therapeutically induced purgation needs to be evaluated for its safety. Thus, the present study was conducted to establish the safety profile of *Virechanakarma* if conducted as per the classical guidelines starting with *Poorvakarma*, followed by *Pradhanakarma*, and finally completing with *Samsarjanakrama*.

To support this hypothesis, the electrolyte study was undertaken before and after the treatment \[[Table 1](#T1){ref-type="table"}\], it is clear that the deviation is within normal range.\[[@ref5][@ref6]\]

In addition to this, the vital parameters like pulse and blood pressure were within the normal limits as \[[Table 2](#T2){ref-type="table"}\].

The clinical features of hyponatremia\[[@ref7]\] hypokalemia\[[@ref8]\] hypocalcemia\[[@ref9]\] were not reported in any of the 15 patients after *Virechanakarma*.

Subjectively, in one of the patients, giddiness was reported due to hypovolemia after *Virechana*, as the number of bouts of evacuations was 32. The condition of the patient was managed by oral rehydration.

Along with this, two patients also complained of cramping of abdominal which subsided by evening in both of them.

Statistically, the results showed significant decrease in levels of serum sodium, potassium and chloride levels and significant increase in level of serum calcium \[[Table 1](#T1){ref-type="table"}\]. But all, the changes were within normal limit.

Though the change in electrolyte levels was statistically significant, they were within the normal range.

Conclusion {#sec1-5}
==========

The present work was a pilot study aimed to ascertain the safety of *Virechanakarma*, which was performed keeping in mind that the *Panchakarma* procedure though efficacious and safe needed an assessment of its safe application in this modern era. Serum electrolytes values were well within the normal ranges in all the 15 patients after the therapeutic purgation. The study was helpful in establishing the safety of therapeutic purgation, i.e. *Virechanakarma* subjectively and statistically as well without causing any adverse effects. However in this study, the sample size was small, so a similar study in a larger sample needs to be conducted to further strengthen the findings of this study. Studies aiming at safe application of other *Panchakarma* therapies can also be conducted using various parameters.
